ArticleDermatology and therapy2026
Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot Study.
Article in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant impact on a patient's daily life, negatively affecting numerous psychological and physical aspects. Thus, patients with HS may be at elevated risk of developing addictive disorders. We therefore aimed to evaluate the prevalence of the most common addictions and psychiatric comorbidities among patients with HS.
methodsThis questionnaire-based pilot study was conducted between January and October 2021 at the Department of Dermatology and Allergology, School of Medicine and Health, Technical University of Munich, Germany. Demographics, disease severity, quality of life, presence of depression and anxiety, addictions including smoking habits, alcohol consumption, consumption of illicit drugs and prescription drugs, cannabis consumption, gambling, internet and food addiction were recorded.
resultsA total of 120 patients (48.3% female, 51.7% male; mean age 39.3 ± 13.2 years) with HS were included. Most patients suffered from mild HS. Screening results for at least one addiction were positive in 71.7% of the participants, while smoking was most prevalent (60.0%), followed by pathological alcohol consumption (18.3%), food addiction (18.3%) and cannabis addiction (15.0%). Moreover, positive screening rates were 13.3% for addiction to illicit drugs or prescription medication, 12.5% for internet addiction and 5% for gambling. Using multivariate logistic regression, the correlation of patients' characteristics with addictive disorders was determined. Younger patients were more susceptible to internet, cannabis and food addiction. Food addiction was more prevalent in patients with an increased BMI. Addiction to illicit drugs or prescription medication was associated with anxiety.
conclusionStrikingly, numerous addictions were recorded in patients with HS, even in those with mild disease severity. Thus, addictions in patients with HS should be addressed in time by physicians to provide early patient-centred health care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.